Please login to the form below
Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine
Latest deal is part of Operation Warp Speed
Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month
Monoclonal antibody has neutralised SARS-CoV-2 virus in vitro
Russia becomes first country to approve a COVID-19 vaccine
Vaccine approved after less than two months of human testing
Novavax plans to meet US COVID-19 vaccine demand in 2021
Company plans to produce two billion doses if vaccine proves effective
Articles
-
AI: the smart money is on the smart thinkingLooking at the three key areas where AI is being applied: drug discovery, clinical decision-making and clinical trials
-
Socially distanced strategisingThe new normal can improve how you create strategy
-
Gut instincts lead Takeda to GI pipeline successTakeda’s Asit Parikh talks about a game changer for IBD patients and the company’s long-term strategy for gene and cell therapy
-
What’s next? How behavioural science can support pharma’s futureBy Dan Coffin
-
The power of remote personal interactions: COVID-19 pandemic and the increasing role of remote engagement By Karen Ticozzi and Liz Murray
Pharmaceutical Market Europe - July/August 2020
Celebrating the virtual Communique Awards 2020 and understanding the importance of behaviour change
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor - Iona Everson
Have your say...
Subscribe
Ex-J&J exec Denice Torres joins bluebird bio’s board
Torres brings over 25 years of executive management experience to the role
'Nothing about us without us'
Why patient engagement is essential throughout the entire product life cycle
COVID-19 Updates and Daily News
Featured jobs
- Roche scores FDA approval for SMA drug risdiplam, now named Evrysdi
- New study identifies drugs that are safe to use in COVID-19 treatment
- How will the events and exhibitions industry change post-Coronavirus?
- Biogen pays Denali $1bn upfront for Parkinson’s disease programme
- Tecentriq combo fails in advanced triple negative breast cancer
- Merck enters agreement with Hanmi for investigational NASH drug
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- OPEN Health at the World Orphan Drug Conference USA
- US pays $1.5bn for 100 million doses of Moderna’s COVID-19 vaccine
- Vir Biotech plans to start mid-to-late stage study of COVID-19 antibody this month
- Russia becomes first country to approve a COVID-19 vaccine
- Can involving patients in design transform the clinical trial experience?
PMHub
3 Monkeys Zeno
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...
Latest intelligence
- Virtual Hackathon on Healthcare Innovation: a Customer Story
- How participants from 9 different countries in the APAC region were brought together to participate in a pharmaceutical company-wide 3-day virtual "hackathon," with spectacular results....
- OPEN Health at the World Orphan Drug Conference USA
- Our Director of Rare Disease, Gavin Jones looks forward to his conversation with Emily Crossle & Betsy Bogard at #WODCUSA2020 !...
- Can involving patients in design transform the clinical trial experience?
- While the research space is a heavily regulated environment and there are rules that we must abide by, this doesn’t mean clinical study materials have to be ‘boring’ or the...
Quick links
Infographics
